All filters
Slidesets
Guidelines for Diagnosis and Treatment of HIV Aids in China (2018) - Taisheng Li, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Study on HIV Variation and Evolution and Its Impact on Molecular Epidemiology and Drug Resistance Surveillance - Yiming Shao, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
HIV Pre-Exposure Prophylaxis (PrEP) - Roy Gulick, MD, MPH (CH)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
HIV Pre-Exposure Prophylaxis (PrEP) - Roy Gulick, MD, MPH (EN)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
PrEP Uptake Preferences Among Men Who Have Sex With Men in China Results From a National Internet Survey - Fujie Zhang, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
HIV Drug Resistance - Charles Boucher, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Novel Treatment Strategies - Two Versus Three Drugs - Jonathan Schapiro, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Progress Review on HIV Cure - Bonaventura Clotet, MD, PhD (CH)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Progress Review on HIV Cure - Bonaventura Clotet, MD, PhD (EN)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
HIV TB Co-infection in China - Hongzhou Lu, MD, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Clinical Management of HIV-HBV and HIV-HCV Coinfection - Jürgen Rockstroh, MD (CH)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Clinical Characteristics and Prognostic Factors of Cryptococcal Meningitis Among HIV-Infected Patients - Yinzhong Shen, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Clinical Management of HIV-HBV and HIV-HCV Coinfection - Jürgen Rockstroh, MD (EN)
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Novel Biomarkers for Chronic Hepatitis B - Xiaonan Zhang, PhD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2019
Slidesets
Oxazolidinones for TB: Current Status and Future Prospects - Lawrence Geiter
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Evaluating Hepatotoxicity of Bedaquiline Treatment in Multi-Drug Resistant Tuberculosis Patients - Lénaïg Tanneau
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Relationship Between Plasma and Intracellular Concentrations of Bedaquiline and its M2 Metabolite in South African Patients with Drug-Resistant TB - Precious Ngwalero
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetics and Early Bactericidal Activity of Meropenem (with Amoxicillin/Clavulanate), With and Without Rifampicin, for Drug-Susceptible TB - Ahmed Aliyu Abulfathi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Co-Administration of Pretomanid with Rifampin or Rifabutin Among Patients with Pulmonary TB: Interim PK Results from “Assessing Pretomanid for Tuberculosis” (APT) Trial - Elisa Ignatius
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Exposures to First-Line Drugs in African and Indian Children with Drug-Susceptible Tuberculosis using Novel Fixed-Dose-Combination Tablets at WHO Dosing Recommendation in the SHINE Trial - Chishala Chabala
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Ethionamide Population Pharmacokinetic Model and Monte Carlo Simulation in Patients with Multidrug-Resistant Tuberculosis - Charles Peloquin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Can Longitudinal PKPD Biomarkers be used to Forecast Treatment Outcome Instead of M2 Conversion? A Population Pharmacokinetic-Pharmacodynamic Analysis in Drug Sensitive Pulmonary Tuberculosis - Frank Kloprogge
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetic-Pharmacodynamic Analysis in TB Drug Development and the Role of the WHO - Ernesto Jaramillo
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
PK-PD of Isoniazid Given at Different Doses Among Patients with MDR-TB with INH Resistance Mediated by inhA Mutations: Modeling Results from ACTG A5312 - Kamunkhwala Gausi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019